Click it and Unblock the Notifications
For Quick Alerts
For Daily Alerts
Just In
Don't Miss
-
Dharamshala Stadium Embraces Cutting-Edge SISGrass Hybrid Pitch Technology To Revolutionise Indian Cricket -
How To Choose Earrings For Your Outfits, 6 Tips To Ace The Art Of Jewellery Selection -
Penny Stock Below Rs 50 Announces Major Update On 6:11 Bonus Shares; Bet? -
From Coconut Breaking on Head to Men Dressing as Women: 12 Unique Indian Rituals Explored -
Thug Life: Rumours Suggest Dulquer Salmaan Is Back In Kamal Haasan's Film; Sources Say Otherwise; Details HERE -
ASUS Zenbook DUO 2024 Launched in India – Check Price, Specs, Where to Buy -
Renault Duster And Nissan Models To Feature Turbo-Petrol Engines: Hybrid In The Makes? -
TN MRB Assistant Surgeon Recruitment 2024; 2553 Vacancies, Application Procedure Selection Details and more
Aurobindo Pharma gets US FDA nod for Bristol's Videx generic
New Delhi, Sept 25 (UNI) Aurobindo Pharma Ltd today said it has received the US Food and Drug Administration (USFDA) approval to sell the generic version of Bristol-Myers Squibb's Videx EC, which is used to treat HIV infection in adults.
With the USFDA nod, the drug maker can sell didanosine delayed release capsule in multiple strengths in the United States, it said in a statement.
UNI
AK
SG
AS1545
Comments
Story first published: Friday, September 26, 2008, 13:01 [IST]
